Tauriga Sciences (TAUG) versus Mannatech (MTEX) Critical Survey

Tauriga Sciences (OTCMKTS:TAUG) and Mannatech (NASDAQ:MTEX) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, valuation, risk, dividends, profitability and analyst recommendations.

Profitability

This table compares Tauriga Sciences and Mannatech’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Tauriga Sciences N/A -60.55% -31.23%
Mannatech -3.43% -2.51% -1.19%

Institutional & Insider Ownership

16.0% of Mannatech shares are owned by institutional investors. 6.2% of Tauriga Sciences shares are owned by insiders. Comparatively, 24.7% of Mannatech shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current ratings and recommmendations for Tauriga Sciences and Mannatech, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tauriga Sciences 0 0 0 0 N/A
Mannatech 0 0 0 0 N/A

Earnings and Valuation

This table compares Tauriga Sciences and Mannatech’s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Tauriga Sciences N/A N/A -$30,000.00 N/A N/A
Mannatech $176.70 million 0.26 -$1.78 million N/A N/A

Tauriga Sciences has higher earnings, but lower revenue than Mannatech.

Dividends

Mannatech pays an annual dividend of $2.00 per share and has a dividend yield of 10.4%. Tauriga Sciences does not pay a dividend. Mannatech has increased its dividend for 2 consecutive years.

Risk & Volatility

Tauriga Sciences has a beta of 0.3, indicating that its share price is 70% less volatile than the S&P 500. Comparatively, Mannatech has a beta of 1.72, indicating that its share price is 72% more volatile than the S&P 500.

Summary

Mannatech beats Tauriga Sciences on 8 of the 10 factors compared between the two stocks.

About Tauriga Sciences

Tauriga Sciences, Inc. produces, licenses, and sells lip balm products under the HerMan brand name. The company was founded in 2001 and is based in New York, New York.

About Mannatech

Mannatech, Incorporated provides wellness solutions. The company develops, markets, and sells nutritional supplements, topical, skin care and anti-aging products, and weight-management products. It markets its products through network marketing channels in the Americas, Europe/the Middle East/Africa, and the Asia/Pacific. The company was founded in 1993 and is headquartered in Coppell, Texas.

Receive News & Ratings for Tauriga Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tauriga Sciences and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply